Valneva SE (EPA:VLA)
3.820
+0.044 (1.17%)
At close: Dec 5, 2025
Valneva SE Employees
Valneva SE had 713 employees as of December 31, 2024. The number of employees increased by 37 or 5.47% compared to the previous year.
Employees
713
Change (1Y)
37
Growth (1Y)
5.47%
Revenue / Employee
€252,331
Profits / Employee
€143,282
Market Cap
656.01M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 153,498 |
| Sanofi | 82,878 |
| Sartorius Stedim Biotech | 9,901 |
| bioMérieux | 14,754 |
| Eurofins Scientific SE | 62,696 |
| Ipsen | 5,358 |
| ABIVAX Société Anonyme | 69 |
| Virbac | 6,365 |
Valneva SE News
- 20 hours ago - VALNEVA Declaration of shares and voting rights: November 30, 2025 - GlobeNewsWire
- 9 days ago - Valneva Posts Positive Lyme Vaccine Booster Results — Pfizer Targeting 2026 Regulatory Filings - Benzinga
- 9 days ago - Valneva Posts Positive Lyme Vaccine Booster Results — Pfizer Targeting 2026 Regulatory Filings - Benzinga
- 9 days ago - Valneva to Further Consolidate its Operations in France - GlobeNewsWire
- 10 days ago - Valneva Shares Rise on Positive Data from Lyme Disease Vaccine Study - WSJ
- 10 days ago - Valneva's Lyme Vaccine VLA15 Shows Strong Phase 2 Booster Results With Favorable Safety - Nasdaq
- 10 days ago - Valneva Announces Positive Final Phase 2 Results for Lyme Disease Vaccine Candidate - GlobeNewsWire
- 15 days ago - Valneva SE (INRLF) Nine Months 2025 Earnings Call Highlights: Revenue Growth Amid Operational ... - GuruFocus